USPTO serial 88373184
ELPIS THE CELL SCIENCE COMPANY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CALLOWAY, CHRISTINA DENISE
- Law office
- TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ELPIS THE CELL SCIENCE COMPANY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Geza C. Ziegler Jr.
GEZA C. ZIEGLER JR. ZIEGLER IP LAW GROUP, LLC55 GREENS FARMS ROADWESTPORT, CT 06880UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research purposes; Stem cells for scientific purposes; Stem cells other than for medical or veterinary purposes; Provision of skeletal myocytes for research purposes; Provision of cortical neurons for research purposes; Biological tissue for research and scientific purposes; Biological tissue cultures other than for medical or veterinary purposes; Cultures of cell media; Chemical reagents for use in biotechnology, other than for medical or veterinary use; Nutritive agents for processing living cells; Semi-processed natural proteins for manufacturing food; Proteins for use in the manufacture of food products; Proteins for use in recombinant DNA technology | ACTIVE | — |
| 005 | Cell therapeutics; Genetically or otherwise modified cells; Cells which are propagated, cultivated and expanded in bioreactors; Cells for the purpose of tissue regeneration; Living cells for medical use; Cells for medical use; Biological preparations for medical use; Diagnostic preparations for medical and/or veterinary purposes; Cell preparations for drug screening; Cell preparations for genetic testing, screening; Stem cells for medical purposes; Stem cells for veterinary purposes; Cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use; Tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells; Cell separation reagents, magnetic cell separation equipment; Dietary supplements; Protein supplements; nutrition supplements | ACTIVE | — |
| 009 | Computer software and computer hardware for the separation of biological and non-biological materials; Bioreactors; Bioreactors for biomanufacturing; Bioreactors for research use; Bioreactor for cell culturing; Bioreactors for laboratory use; Manufacturing software; Smart manufacturing system controls; Electronic control units | ACTIVE | — |
| 029 | Meat; Meat substitutes; Tissue engineered meat; Synthetic meat; Cultured meat; Laboratory-grown meat; Fish, not live | ACTIVE | — |
| 042 | Biotechnology research; Biotechnology testing; Stem cell research; Synthetic biology services; Stem cell biology services; Scientific services relating to the isolation and cultivation of human tissues and cells; Research and development in the field of microorganisms and cells; Research and development in relation to genetic testing, screening; Research and development in relation to drug screening; Cell separation technology services; Cell separation research services; Consultancy relating to biotechnology; Consultancy relating to drug screening; Consultancy relating to genetic screening; Consultancy relating to cell therapy; Laboratory research; Research on food; Research and development in the field of animal cells cultivated within bioreactors; Research in the reduction of carbon emissions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Elpis Biomed Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 029
- Other trademarks in Class 042
- Similar marks named ELPIS THE CELL SCIENCE COMPANY
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 7, 2020 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 7, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 26, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 26, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 26, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 25, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 23, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 9, 2019 | NWAP | NEW APPLICATION ENTERED | — |